Project Details
| Status | Active |
|---|---|
| Effective start/end date | 25/12/21 → 24/12/26 |
Keywords
- phase 3 and 4 study
- breast cancer
- multicentre trial
Clinical Trial Phase
- Phase IV
- Phase III (a & b)
An Open-Label, Multinational, Multicenter, Phase 3b/4 Study of Trastuzumab Deruxtecan in Patients With or Without Baseline Brain Metastasis With Previously-Treated Advanced/Metastatic HER2-Positive Breast Cancer (DESTINY-Breast12)
- McCartney, Amelia (Primary Chief Investigator (PCI))
Project: Research